Procaps Group, S.A Share Holder Equity 2020-2023 | PROCF
Procaps Group, S.A share holder equity from 2020 to 2023. Share holder equity can be defined as the sum of preferred and common equity items
Procaps Group, S.A Annual Share Holder Equity
(Millions of US $) |
| 2022 |
$-2 |
| 2021 |
$-38 |
| 2020 |
$-255 |
| 2020 |
$5 |
| 2019 |
$ |
| 2019 |
$0 |
| 2018 |
$0 |
Procaps Group, S.A Quarterly Share Holder Equity
(Millions of US $) |
| 2023-09-30 |
$38 |
| 2023-06-30 |
$32 |
| 2023-03-31 |
$5 |
| 2022-12-31 |
$-2 |
| 2022-09-30 |
$-11 |
| 2022-06-30 |
$-30 |
| 2022-03-31 |
$-20 |
| 2021-12-31 |
$-38 |
| 2021-09-30 |
$36 |
| 2021-06-30 |
$-29 |
| 2021-03-31 |
$-23 |
| 2020-12-31 |
$-255 |
| 2020-09-30 |
$5 |
| 2020-06-30 |
$5 |
| 2020-03-31 |
$5 |
| 2019-12-31 |
$5 |
| 2019-09-30 |
$0 |
| 2019-06-30 |
$0 |
| 2019-03-31 |
$0 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-DRUGS |
$0.125B |
$0.410B |
|
Procaps Group is a developer of pharmaceutical and nutraceutical solutions, medicines and hospital supplies. It develops, manufactures and markets over-the-counter and prescription drugs, nutritional supplements and high-potency clinical solutions. Procaps Group, formerly known as Union Acquisition Corp. II, is based in BARRANQUILLA, Colombia.
|
